$24.08
0.54% today
Nasdaq, Dec 30, 10:00 pm CET
ISIN
US8523123052
Symbol
STAA

STAAR Surgical Company Target price 2024 - Analyst rating & recommendation

STAAR Surgical Company Classifications & Recommendation:

Buy
54%
Hold
38%
Sell
8%

STAAR Surgical Company Price Target

Target Price $40.81
Price $24.21
Potential
Number of Estimates 10
10 Analysts have issued a price target STAAR Surgical Company 2025 . The average STAAR Surgical Company target price is $40.81. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 13 analysts: 7 Analysts recommend STAAR Surgical Company to buy, 5 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the STAAR Surgical Company stock has an average upside potential 2025 of . Most analysts recommend the STAAR Surgical Company stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 322.42 342.50
13.37% 6.23%
EBITDA Margin 10.30% 12.28%
39.35% 19.18%
Net Margin 6.57% 1.67%
52.59% 74.59%

13 Analysts have issued a sales forecast STAAR Surgical Company 2024 . The average STAAR Surgical Company sales estimate is

$342m
Unlock
. This is
0.37% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$344m 0.93%
Unlock
, the lowest is
$339m 0.65%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $322m 13.37%
2024
$342m 6.23%
Unlock
2025
$383m 11.91%
Unlock
2026
$436m 13.85%
Unlock
2027
$525m 20.40%
Unlock
2028
$610m 16.19%
Unlock

8 Analysts have issued an STAAR Surgical Company EBITDA forecast 2024. The average STAAR Surgical Company EBITDA estimate is

$42.0m
Unlock
. This is
33.10% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$44.7m 41.50%
Unlock
, the lowest is
$38.9m 23.03%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $33.2m 31.24%
2024
$42.0m 26.57%
Unlock
2025
$55.2m 31.23%
Unlock
2026
$83.2m 50.87%
Unlock
2027
$126m 50.88%
Unlock
2028
$160m 27.23%
Unlock

EBITDA Margin

2023 10.30% 39.35%
2024
12.28% 19.18%
Unlock
2025
14.40% 17.26%
Unlock
2026
19.08% 32.50%
Unlock
2027
23.91% 25.31%
Unlock
2028
26.18% 9.49%
Unlock

10 STAAR Surgical Company Analysts have issued a net profit forecast 2024. The average STAAR Surgical Company net profit estimate is

$5.7m
Unlock
. This is
73.61% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$9.4m 56.82%
Unlock
, the lowest is
$-990k 104.57%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $21.2m 46.25%
2024
$5.7m 73.00%
Unlock
2025
$15.6m 172.20%
Unlock
2026
$34.7m 123.12%
Unlock
2027
$45.3m 30.48%
Unlock
2028
$60.4m 33.16%
Unlock

Net Margin

2023 6.57% 52.59%
2024
1.67% 74.59%
Unlock
2025
4.06% 143.11%
Unlock
2026
7.96% 96.06%
Unlock
2027
8.63% 8.42%
Unlock
2028
9.89% 14.60%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ 0.43 0.12
46.25% 72.09%
P/E 208.71
EV/Sales 2.91

10 Analysts have issued a STAAR Surgical Company forecast for earnings per share. The average STAAR Surgical Company <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$0.12
Unlock
. This is
72.73% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$0.19 56.82%
Unlock
, the lowest is
$-0.02 104.55%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $0.43 46.25%
2024
$0.12 72.09%
Unlock
2025
$0.32 166.67%
Unlock
2026
$0.71 121.88%
Unlock
2027
$0.92 29.58%
Unlock
2028
$1.23 33.70%
Unlock

P/E ratio

Current 55.26 31.29%
2024
208.71 277.69%
Unlock
2025
76.61 63.29%
Unlock
2026
34.34 55.18%
Unlock
2027
26.32 23.35%
Unlock
2028
19.76 24.92%
Unlock

Based on analysts' sales estimates for 2024, the STAAR Surgical Company stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.92 34.97%
2024
2.91 0.31%
Unlock
2025
2.60 10.65%
Unlock
2026
2.28 12.16%
Unlock
2027
1.90 16.95%
Unlock
2028
1.63 13.93%
Unlock

P/S ratio

Current 3.50 29.77%
2024
3.48 0.37%
Unlock
2025
3.11 10.64%
Unlock
2026
2.73 12.16%
Unlock
2027
2.27 16.94%
Unlock
2028
1.95 13.93%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today